Pfizer (PFE)

EBITDA Margin

21.18%

TTM · Period ending:

PFE logo

PFE EBITDA Margin

Latest reported21.18%
PFE EBITDA Margin (25.08% → 21.18%)
High-resolution chart · PNG

PFE ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
26.8189%
28.4895%
16.0479%
40.896%
37.8814%
31.8456%
45.6937%
36.5072%
37.765%
28.9527%
31.3627%
38.5788%
45.6343%
37.3584%
36.3529%
29.1782%
33.6279%
31.6796%
30.7157%
38.8849%
35.5384%
37.0306%
31.8447%
40.9508%
35.9156%
32.2513%
48.5497%
45.3928%
27.999%
27.4368%
29.2793%
27.3447%
15.6666%
23.6135%
21.5482%
19.9594%
20.7229%
22.4013%
22.4155%
24.7274%
25.0839%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.